The prevalence of hepatitis E virus (HEV) among Slovenian blood donors was assessed using NAT screening tests to detect HEV RNA in serum and serological analysis of specific antibodies. We tested 8,928 blood donor samples for the presence of HEV RNA and 600 samples for specific IgG and IgM anti-HEV antibodies. The occurrence of HEV RNA was low (0.02 %), with only two positive samples, while the seroprevalence of IgG anti-HEV antibodies was 7.3 %, indicating past infection in approximately one in 14 blood donors. Acute infections were rare, but their early detection is crucial for preventing transmission through blood transfusion. Antibody avidity analysis allowed differentiation between recent and past infections. Samples were collected from all Slovenian regions, ensuring the representativeness of the results. Our findings indicate that the risk of HEV transmission through blood transfusion is low; however, continued monitoring remains necessary. Routine HEV RNA screening and improved diagnostic methods could further reduce the possibility of transmission. This study provides important epidemiological data to enhance transfusion safety in Slovenia and highlights the need for development of effective strategies for infection prevention.
|